Atrioventricular block

Articolo redatto e revisionato del Dott. Luca Moretti

Atrioventricular block is an abnormality of impulse transmission from the atria to the ventricles that may present as simple delay, failure to conduct some impulses, or complete interruption of the effective electrical connection. The definition includes patterns with profoundly different significance: isolated PR prolongation in a healthy person is not equivalent to intermittent His-Purkinje block, even when both are discovered without symptoms. Assessment must establish which component of conduction is involved and how reliable residual ventricular activation is.

The term degree describes electrocardiographic behavior, whereas risk also depends on level, cause, frequency of occurrence, escape rhythms, and associated heart disease. This distinction guides the entire clinical pathway: recognizing the block, documenting its relationship with the patient's symptoms, identifying reversible causes, and deciding whether protection by pacing is required. An apparently mild tracing may require attention when associated with syncope or progressive disease, while a striking sequence of grouped beats may instead have a functional nodal origin.

Electrocardiographic classification and anatomical localization

In first-degree block, atrioventricular conduction remains 1:1, but in adults the PR interval exceeds 200 milliseconds. It is therefore a delay, not loss of an impulse. The site may be nodal, intra-Hisian, or more distal, and part of the prolongation may reflect atrial conduction. The PR interval should be interpreted together with sinus rate, QRS duration, and previous ECGs. A markedly prolonged interval may impair mechanical coordination even though every P wave continues to be followed by a ventricular complex.

In second-degree block, some atrial depolarizations do not reach the ventricles. Mobitz I is characterized by a sequence with changing PR intervals and a nonconducted impulse, typically preceded by progressive prolongation and followed by a shorter PR. In Mobitz II, a nonconducted P wave occurs with constant PR intervals before and after the block in the setting of a stable sinus rate. Distinguishing the two patterns requires a recording that adequately shows conducted beats; observing a pause or a single apparently unchanged PR interval is not enough.

2:1 block cannot automatically be classified as Mobitz I or II because only one beat is conducted between two blocked P waves and there is insufficient sequence to analyze PR evolution. The level must be inferred from associated findings, behavior over time, and, when necessary, targeted investigations. Advanced block refers to failure of conduction of several consecutive atrial impulses while occasional transmission remains recognizable. A high-grade conduction ratio likewise describes the degree of conduction loss, not the anatomical level by itself.

In complete block, no atrial impulse is effectively transmitted to the ventricles, which are sustained by a junctional or ventricular escape rhythm when one is available. Atria and ventricles therefore follow independent rhythms. Atrioventricular dissociation, however, is not synonymous with complete block: it may also occur when a junctional or ventricular rhythm competes with sinus rhythm and temporarily renders the conduction tissue refractory. Diagnosis requires determining whether atrial impulses have genuine opportunities to conduct and whether capture beats are seen.

The distinction between nodal and infranodal block has prognostic value. The atrioventricular node is strongly modulated by the autonomic nervous system and often responds favorably to reduced vagal tone; a lesion in the His bundle or bundle branches may instead impair ventricular activation unpredictably. A narrow QRS makes a proximal level more likely in some settings but does not exclude an intra-Hisian lesion. Similarly, a wide QRS may reflect pre-existing bundle branch block associated with nodal block: morphology and level must be correlated rather than treated as equivalent.

Mechanisms, causes, and intermittent forms

Nodal conduction depends on the availability of depolarizing currents, refractoriness, and the time elapsed since the preceding impulse. Increased vagal tone can slow both the sinus node and atrioventricular node, producing longer PR intervals and nonconducted impulses. Sinus slowing around the time of block is an important clue to this mechanism. It may occur during sleep, visceral reflexes, or reflex syncopal episodes, but interpretation must also consider the vasodepressor component, which a pacemaker does not directly correct.

His-Purkinje disease may result from degenerative fibrosis, ischemia, inflammatory injury, or inherited abnormalities. The tissue loses its ability to propagate reliably impulses that would normally be conducted rapidly. Appearance of block may depend on heart rate or particular activation sequences and may not be constant on the baseline ECG. Paroxysmal block can therefore explain sudden episodes of syncope even when heart rate and conduction appear normal during the clinical visit.

In acute coronary syndrome, the significance of block depends on the ischemic territory, level, and hemodynamic status. Nodal involvement during inferior infarction may regress as ischemia and autonomic influences resolve; distal impairment associated with anterior infarction and bundle branch block suggests more extensive injury. Treatment of ischemia and protection from bradycardia must proceed in a coordinated fashion. The possibility of recovery does not justify delaying support when cardiac output is inadequate.

Systemic and infectious causes should be investigated according to the patient's profile. Cardiac sarcoidosis, myocarditis, amyloidosis, neuromuscular diseases, and some genetic cardiomyopathies may present with conduction disorders. Lyme carditis is a relevant possibility when epidemiologic exposure and compatible manifestations are present; new block during endocarditis may indicate perivalvular extension of infection. These scenarios require their own therapies and investigations: device implantation, when needed, does not complete treatment of the cause.

Drugs and metabolic disturbances can reduce conduction reserve. Beta-blockers, non-dihydropyridine calcium-channel blockers, digoxin, and some antiarrhythmic drugs require careful review, including interactions and renal function. Hyperkalemia can simultaneously alter atrial activity, PR, and QRS, producing severe patterns. After surgery, ablation, or valve procedures, block may reflect transient edema or persistent injury. Even initial regression requires assessment of recurrence probability, especially when conduction abnormalities were present before the event.

Hemodynamic consequences and clinical presentation

The effective ventricular rate partly determines cardiac output, but beat count does not describe the entire impairment. Pause duration, ability to increase rate during exercise, ventricular function, and atrioventricular synchrony also matter. A patient may tolerate reduced conduction at rest and develop dyspnea or weakness as soon as metabolic demand rises. Structural heart disease often reduces compensatory capacity and makes an electrical change clinically relevant that would be better tolerated in a healthy heart.

Sudden-onset forms can cause presyncope or loss of consciousness, sometimes without prodromes. A long ventricular pause may precede emergence of the escape rhythm, whereas a slow or unstable replacement rhythm may not maintain adequate perfusion. Severe cases may present with hypotension, altered mental status, ischemic pain, pulmonary edema, or cardiac arrest. Recognition of circulatory compromise takes precedence over immediate completion of detailed electrocardiographic classification.

In marked atrioventricular delay, the problem may be primarily mechanical. Atrial activation occurring too early relative to the subsequent ventricular systole makes the atrial contribution to filling ineffective and may be associated with diastolic mitral regurgitation or increased atrial pressures. The patient may report fatigue, dyspnea, neck pulsations, or reduced exercise capacity despite maintaining 1:1 conduction. Similarity to some disorders caused by suboptimal pacemaker programming has led to the description of a pseudo-pacemaker syndrome.

Some patients have subtle symptoms and unknowingly modify their activities. Slowing their pace, avoiding stairs, or stopping exertion early may conceal functional limitation. The history should therefore explore concrete changes from the usual level without automatically attributing fatigue or dizziness to the block. Anemia, thyroid dysfunction, hypotensive drugs, respiratory disease, and deconditioning may explain some symptoms and should be considered when their temporal relationship with the arrhythmia is weak.

Absence of symptoms has different meanings depending on the mechanism. In mild nodal block it may support conservative management; in true Mobitz II or nonreversible acquired complete block it does not eliminate the risk of sudden events. Conversely, documenting syncope in a patient with a prolonged PR interval does not prove that the PR interval caused it. Clinical reasoning must avoid both false reassurance based on momentary well-being and causal attribution of every symptom to a concomitant electrical finding.

Diagnosis, documentation, and distinction from pseudo-block

Interpretation of the ECG should begin with atrial activity. Regularity and morphology of P waves are reconstructed, including those hidden in the T wave or QRS, and then which P waves are conducted and with what PR interval are analyzed. Comparison of PR intervals before and after a pause is particularly useful in second-degree block. QRS duration, bundle branch configuration, and escape rhythm complete the analysis. A long, clean strip with leads that display P waves well may resolve uncertainties left by an automated report.

Blocked premature atrial contractions are a frequent source of error. A premature impulse may arrive while the node is refractory and fail to produce a QRS complex; the premature P wave, sometimes deforming the T wave, distinguishes this situation from failure of an expected sinus P wave to conduct. Concealed junctional premature beats may also interfere with subsequent conduction and mimic block. Advanced conduction system disease should not be diagnosed without considering these possibilities, especially in inconsistent or atypical tracings.

Ambulatory monitoring should make it possible both to record the event and understand its context. Symptom diaries, timing of medications, activity, and sleep help distinguish vagal episodes, exercise-related block, and unpredictable events. Event frequency guides recording duration. A short negative recording has little exclusionary power when syncope occurs months apart; conversely, an isolated nocturnal finding should not automatically be used to explain a noncontemporaneous daytime symptom.

Structural and etiologic assessment includes echocardiography and targeted investigations. Electrolytes and renal function are especially relevant in acute or drug-related forms; other tests depend on endocrine, infectious, or inflammatory suspicion. Cardiac magnetic resonance can identify scar or an associated myocardial process, while additional imaging is selected according to the suspected disease. Etiologic diagnosis is especially important in younger patients or those with ventricular arrhythmias because it may also change the appropriate type of device.

Exercise testing and electrophysiological study have complementary indications. Improvement of conduction with activity favors a functional nodal component, whereas worsening may raise suspicion of distal disease without constituting absolute anatomical proof. Recording His potentials localizes the delay and may document intra-Hisian or infra-Hisian block. Provocative testing requires a protected setting and a defined question; it should not be used to test an already unstable patient or delay clearly necessary pacing.

Acute treatment and indications for permanent pacing

In forms with hypoperfusion, management is based on assessment of vital functions, continuous monitoring, and immediate availability of defibrillation and pacing. Ischemia, electrolyte abnormalities, toxicity, and other correctable causes are sought rapidly. Oxygen is administered when indicated by respiratory status and oxygenation. The goal is not to normalize a number on the monitor but to restore adequate perfusion and prevent dangerous pauses while the mechanism of block is clarified.

Atropine may improve nodal conduction, especially in vagal patterns, but it does not guarantee a response in His-Purkinje disease. Atrial acceleration may even increase the number of blocked impulses if distal tissue cannot conduct them. With an inadequate response or high-risk block, transcutaneous pacing and, as necessary, transvenous pacing provide support. Capture must also be confirmed mechanically because a stimulus followed by an apparent electrical signal alone does not prove effective circulation.

Infused chronotropic drugs may serve as a bridge in selected situations, with monitoring for ischemia, blood pressure, and arrhythmias. Temporary transvenous pacing is reserved for settings in which benefit exceeds the risks of infection, thrombosis, perforation, and lead instability. If block is persistent and nonreversible and the definitive indication is established, a permanent device should be planned without unnecessarily prolonging a temporary solution. With reversible causes, support duration instead depends on response to therapy and reliability of recovered conduction.

For acquired Mobitz II, advanced block, and complete block not attributable to reversible or physiologic causes, the indication for permanent pacing may be prognostic and independent of symptoms. In first-degree block and nodal Mobitz I, implantation is generally considered when there is a demonstrable relationship with relevant symptoms or a particular risk setting. Demonstration of infranodal disease changes the interpretation of an apparently less severe pattern. Neuromuscular, genetic, or infiltrative diseases also require specific criteria.

Choice of the type of pacing considers atrial rhythm, systolic function, and expected percentage of ventricular pacing. Maintaining atrioventricular synchrony is important in sinus rhythm; when frequent ventricular pacing is expected, the risk of dyssynchrony should be reduced. Conduction system pacing and biventricular resynchronization are assessed according to the clinical profile and evidence without assuming that one technique is always superior. Any indication for a defibrillator depends on the underlying disease and ventricular risk, not on the presence of block alone.

Course, follow-up, and prevention of complications

Recovery of conduction should be interpreted in light of the cause. Vagal block may disappear when the stimulus ends; an electrolyte disturbance may correct rapidly; inflammatory or procedure-related injury may follow different time courses. Regression after withdrawal of a drug does not guarantee that the drug was the only cause. Previous ECGs, residual abnormalities, future need for therapy, and severity of the episode help determine whether additional monitoring or definitive protection is needed.

Intermittent block is a particular problem because risk may be concentrated in brief and unpredictable events. Documentation should include, when possible, the onset of the episode, sinus behavior, and recovery from block. This information distinguishes intrinsic and reflex mechanisms better than pause duration alone. In patients with unexplained syncope, absence of block during a short hospital stay does not automatically end the investigation, especially when signs of distal conduction system disease are present.

After implantation, programming must balance preservation of spontaneous conduction and mechanical coordination. Reducing ventricular pacing may be advantageous in some patients, but allowing excessively long atrioventricular intervals may worsen symptoms and filling. Device recordings must be correlated with clinical status and ventricular function. Development of dyspnea or reduced ejection fraction requires assessment of the heart disease and the contribution of pacing, with modification of the strategy when appropriate.

Long-term risk does not necessarily disappear when bradycardia is corrected. In cardiomyopathy, sarcoidosis, or genetic disease, risks of heart failure and ventricular arrhythmias may persist. Identification of relatives who should be evaluated and any genetic counseling derive from the disease diagnosis, not from the simple presence of an abnormal PR interval. In frail patients, therapeutic decisions should also consider goals of care, independence, and the expected benefit of intervention.

Clinical communication should clearly state the degree, probable level, suspected cause, and relationship with symptoms. Generic expressions such as “heart block” do not help define risk or plan follow-up. Precise documentation makes continuity of care safer, particularly when the patient takes medications that affect conduction or is undergoing procedures. Effective management comes from integrating the tracing with its context: the device protects against insufficient ventricular activation, while treatment of the disease and surveillance determine the overall outcome.